Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...
Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company on a mission to revolutionize the field of neuromodulation with an...
Saluda Medical Pty Limited ("Saluda Medical"), a global company on a mission to revolutionize the field of neuromodulation with an emerging portfolio ...
Saluda Medical Pty Limited ("Saluda Medical"), the pioneer in neuromodulation platform of closed-loop technologies designed to achieve unparalleled...
Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of closed-loop spinal cord stimulation (SCS) for the treatment of ...
Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of novel closed-loop spinal cord stimulation (SCS) for the...
Saluda Medical Pty Limited ("Saluda Medical"), the market leader in the development of closed-loop spinal cord stimulation for the treatment of...
Saluda Medical Pty Limited ("Saluda Medical"), developer of the Evoke® Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic...
Saluda Medical Pty Limited ("Saluda Medical") announced today that the UK's National Institute for Health and Care Excellence (NICE) issued a Medtech ...
Saluda Medical Pty Limited ("Saluda Medical"), a global neuromodulation company leading the development and commercialization of data-driven,...
Saluda Medical Pty Limited ("Saluda Medical") heeft vandaag bekendgemaakt dat nieuwe data zijn gepresenteerd uit meerdere studies ter evaluatie van...
Saluda Medical Pty Limited ("Saluda Medical") heeft vandaag bekendgemaakt dat data uit meerdere studies die een beoordeling geven van het Evoke®...
Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke® ECAP-Controlled,...
Saluda Medical Pty Limited ("Saluda Medical") maakte vandaag bekend dat het tijdschrift The Lancet Neurology de resultaten heeft gepubliceerd van een ...
Saluda Medical Pty Limited ("Saluda Medical") today announced The Lancet Neurology journal published results from the U.S. Pivotal Study...
Saluda Medical Pty Limited ("Saluda Medical") kondigde vandaag de toekenning van de CE-markering aan en de Europese commerciële lancering van het...
Saluda Medical Pty Limited ("Saluda Medical") today announced the award of CE Mark and the European commercial launch of the Evoke® ECAP-Controlled,...
Saluda Medical Pty Limited ("Saluda Medical") today announced that it has secured $75 million in equity financing from Boston Scientific Corporation...
Saluda Medical Pty Limited ("Saluda Medical") today announced that it has secured a four-year term loan agreement with Medtronic, to fund continued...
Saluda Medical Pty Limited ("Saluda Medical") today announced data from two clinical studies evaluating the performance of the company's Evoke®...
Saluda Medical Pty Limited ("Saluda Medical") today announced that new data from multiple studies evaluating the company's Evoke® ECAP-Controlled,...
Saluda Medical Pty Limited, a medical device company developing a platform of closed-loop neuromodulation technologies based on neural response to...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.